Cognitive, Motor and Oculomotor Contributions to the Trail Making Test in Progressive Supranuclear Palsy [0.03%]
进行性核上性麻痹患者执行轨道测验时所需的认知、运动和眼动因素分析
Indira Garcia-Cordero,Mohsen Hadian,Juan Camilo Vargas-Gonzalez et al.
Indira Garcia-Cordero et al.
Background: Progressive supranuclear palsy (PSP) is a neurodegenerative disorder characterized by motor, oculomotor and cognitive impairments. Yet disentangling cognitive deficits from motor and oculomotor dysfunction rem...
"Hysteria Septentrionalis": Early Descriptions of Startle Syndromes [0.03%]
《北方狂躁症》：,startle综合征早期的描述
Diederik F Janssen
Diederik F Janssen
What Determines the Clinical Course and Outcome of DPPX Encephalitis? A Systematic Review [0.03%]
DPPX脑炎的临床病程和结局决定因素系统评价
Somdattaa Ray,Tinku Thomas,Vikram Kamath
Somdattaa Ray
Background: Dipeptidyl peptidase like protein 6 (DPPX) encephalitis is a rare type of autoimmune encephalitis. It presents with a plethora of clinical manifestations and variable disease course. ...
ON/OFF Phenomenon in 4-Aminopyridine Therapy in Spinocerebellar Ataxia 27B: Therapeutic and Diagnostic Insights [0.03%]
延髓脑桥型脊小脑性共济失调27B的开/关现象及其诊疗意义
Chiara Caneda,Eleonora Bertoncello,Alessia Peghin et al.
Chiara Caneda et al.
Refining the Biological Classification of Sporadic Parkinson's Disease at Motor Symptom Onset [0.03%]
基于运动障碍的散发性帕金森病的生物学分类修订
Vittorio Velucci,Giovanni Defazio
Vittorio Velucci
Placebo Effect in Levodopa-Induced Dyskinesia: A Systematic Review and Meta-Analysis [0.03%]
左旋多巴引起的异动症的安慰剂效应：系统评价和荟萃分析
Luiz Vinicius Silva Correa,Alexandre Martins do Nascimento,Bruno Lopes Santos-Lobato et al.
Luiz Vinicius Silva Correa et al.
Background: Levodopa-induced dyskinesia (LID) is a complication of Parkinson's disease (PD) treatment. While the placebo effect is a known component in PD clinical trials, its specific magnitude in the context of LID is n...
Real-World Patterns of Botulinum Toxin Treatment in Hyperkinetic Movement Disorders: A 9-Year Nationwide Analysis in France [0.03%]
肉毒杆菌治疗肌张力障碍的现实模式——一项为期九年的全国性分析研究报告
Marion Simonetta-Moreau,Pierre Karam,Anne Forestier et al.
Marion Simonetta-Moreau et al.
Background: Hyperkinetic movement disorders, including dystonia, tremor, and myoclonus, are disabling conditions often managed with botulinum toxin type A (BoNT-A). Real-world evidence on treatment patterns remains limite...
Hemi-Chorea in Anti-GQ1b Syndrome: Expanding the Movement Disorder Spectrum [0.03%]
抗GQ1b抗体综合征的半侧舞蹈症：运动障碍谱系的新发现
Ashutosh Gupta
Ashutosh Gupta
Re-Emergent Postural Tremor Without Clinical Resting Tremor in Parkinson's Disease-A Case Report [0.03%]
帕金森病姿势性震颤再发一例报告
Kevin R E van den Berg,Rick C Helmich
Kevin R E van den Berg
A Schizophrenia-Spectrum Presentation with Panda Sign: Huntington's Disease Confirmed, Wilson Disease Excluded [0.03%]
具有熊猫征的精神分裂症谱系表现：排除威尔森氏病确诊亨廷顿舞蹈病
Eva-Maria Tsapakis,Georgia Zafeiridou,Elizabeth Psoma et al.
Eva-Maria Tsapakis et al.